Leukeran is a synthetic alkylating agent used in oral chemotherapy that works by adding cross-linking groups to dna. The active metabolite chlorambucil penetrates cells and reacts with guanine bases to prevent accurate dna replication. This interference halts the progression of the cell cycle in rapidly dividing malignant cells. The resulting dna damage triggers apoptosis and reduces the population of abnormal blood cells. Clinically the drug is employed to treat certain leukemias and lymphomas by suppressing uncontrolled cell growth. Its therapeutic effect derives from sustained dna cross-linking that ultimately leads to cancer cell death.

Leukeran is a chemotherapy medication classified as an alkylating agent. Its active ingredient is chlorambucil, which functions by alkylating dna in malignant cells. This chemical modification prevents dna replication and triggers apoptosis in rapidly dividing cancer cells. The drug is administered orally and is absorbed into the bloodstream where it reaches target tissues. Once inside cells Leukeran interacts with nucleophilic sites on dna to form covalent cross-links that disrupt replication. The resulting dna damage impairs the ability of cancer cells to repair their genetic material leading to cell death. Clinically Leukeran is used as part of combination regimens for certain lymphomas and chronic lymphocytic leukemia.

Leukeran may cause nausea and vomiting in many patients. It can also lead to diarrhea and a reduced appetite. Some individuals experience mouth sores or inflammation of the lining of the mouth. The medication often results in lowered blood cell counts including anemia and leukopenia. These effects can increase the risk of infections and fatigue. Most side effects are dose dependent and are monitored by healthcare providers.

Leukeran may cause nausea in some patients. Fatigue can occur as a frequent side effect. Changes in blood cell counts are often observed during treatment. Loss of appetite sometimes accompanies the therapy. Mouth sores can develop during the course of treatment. Skin changes such as rash may appear occasionally. Some individuals experience temporary hair thinning. Most side effects are mild and often improve over time.